Yan Li

Shenyang Pharmaceutical University CN

0000-0003-0316-7810

154

Publications

3,972

Citations

H-Index

i10-Index

2.23

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

152 total

Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab

David R. Gandara, Sarah Paul, Marcin Kowanetz, Erica Schleifman, Wei Zou et al. - Nature Medicine, 2018

Cited by 1,190 OpenAlex

Research Topics

Acute Myeloid Leukemia Research (13) Cancer-related molecular mechanisms research (8) Acute Lymphoblastic Leukemia research (8) Chronic Myeloid Leukemia Treatments (8) Endometrial and Cervical Cancer Treatments (7)

Affiliations

BGI Group (China)

CN 2023 - 2023

Shihezi University

CN 2022 - 2022

Shenyang Pharmaceutical University

CN 2025 - 2025

Handan College

CN 2018 - 2018

Tongji University

CN 2022 - 2022

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers

Yan Li

Publication & Citation Trends

Publications

Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back